The urogenital system and the menopause

被引:74
作者
Calleja-Agius, J. [1 ,2 ]
Brincat, M. P. [3 ]
机构
[1] Univ Malta, Mater Dei Hosp, Dept Obstet & Gynaecol, Msida, Malta
[2] Univ Malta, Dept Anat, Msida, Malta
[3] Mater Dei Hosp, Dept Obstet & Gynaecol, L Imsida, Malta
关键词
UROGENITAL ATROPHY; ESTROGEN; GENITOURINARY SYNDROME OF MENOPAUSE; STRESS URINARY INCONTINENCE; HORMONE REPLACEMENT THERAPY; VAGINAL RING; POSTMENOPAUSAL WOMEN; RECEPTOR; ATROPHY; MANAGEMENT; HEALTH; VULVAR; CREAM; FLORA;
D O I
10.3109/13697137.2015.1078206
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The major cause of urogenital atrophy in menopausal women is estrogen loss. The symptoms are usually progressive in nature and deteriorate with time from the menopausal transition. The most prevalent urogenital symptoms are vaginal dryness, vaginal irritation and itching. The genitourinary syndrome of menopause includes vulvovaginal atrophy and the postmenopausal modifications of the lower urinary tract. Dyspareunia and vaginal bleeding from fragile atrophic skin are common problems. Other urogenital complaints include frequency, nocturia, urgency, stress urinary incontinence and urinary tract infections. Atrophic changes of the vulva, vagina and lower urinary tract can have a large impact on the quality of life of the menopausal woman. However, hormonal and non-hormonal treatments can provide patients with the solution to regain the previous level of function. Therefore, clinicians should sensitively question and examine menopausal women, in order to correctly identify the pattern of changes in urogenital atrophy and manage them appropriately.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 40 条
  • [1] ACOG Practice Bulletin, 2001, OBSTET GYNECOL S11, V97
  • [2] [Anonymous], 2005, INT J GYNECOL OBSTET, V88, P222
  • [3] [Anonymous], 2007, TREATMENT POSTMENOPA
  • [4] A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy
    Ayton, RA
    Darling, GM
    Murkies, AL
    Farrell, EA
    Weisberg, E
    Selinus, I
    Fraser, IS
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (04): : 351 - 358
  • [5] BACHMANN GA, 1989, OBSTET GYNECOL, V73, P425
  • [6] Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy
    Barentsen, R
    vandeWeijer, PHM
    Schram, JHN
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 71 (01) : 73 - 80
  • [7] Urogenital ageing and its effect on sexual health in older British women
    Barlow, DH
    Cardozo, LD
    Francis, RM
    Griffin, M
    Hart, DM
    Stephens, E
    Sturdee, DW
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (01): : 87 - 91
  • [8] A study of European womens' experience of the problems of urogenital ageing and its management
    Barlow, DH
    Samsioe, G
    vanGeelen, JM
    [J]. MATURITAS, 1997, 27 (03) : 239 - 247
  • [9] The effect of menopause on the skin and other connective tissues
    Calleja-Agius, J.
    Brincat, M.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (04) : 273 - 277
  • [10] Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius, Jean
    Brincat, Mark P.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2008, 20 (06) : 513 - 518